Hypha Labs (FUNI) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)
Hypha Labs (FUNI) Net Income towards Common Stockholders Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 8.66% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 56.76% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 15.11% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 57.67% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -9.74% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -27.15% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -11.91% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 15.10% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 12.89% |
| 10 | Hypha Labs | 2.26 Mn | 2.18 Mn | - | 18.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.81% |
| Dec 31, 2025 | 61.06% |
| Mar 31, 2025 | -318.94% |
| Dec 31, 2024 | -557.80% |
| Mar 31, 2024 | 422.85% |
| Dec 31, 2023 | 221.76% |
| Sep 30, 2023 | 419.52% |
| Jun 30, 2023 | 359.30% |
| Mar 31, 2023 | 623.17% |
| Dec 31, 2022 | 48.84% |
| Sep 30, 2022 | 125.90% |
| Jun 30, 2022 | 76.33% |
| Mar 31, 2022 | -158.88% |
| Dec 31, 2021 | -20.25% |
| Sep 30, 2021 | 66.52% |
| Jun 30, 2021 | 60.25% |
| Mar 31, 2021 | 102.89% |
| Dec 31, 2020 | -61.80% |
| Sep 30, 2020 | -171.77% |
| Jun 30, 2020 | -0.80% |